ArticleIn vitro cellular & developmental biology. Animal2026

Corydaline overcomes doxorubicin resistance in oral cancer by activating the p53-Bax-caspase axis and inhibiting MMP-driven invasion: an in vitro, in vivo, and in silico study.

Siwei Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.